CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX) Insider Trading
Directors, officers and holders of more than 10% of CTMX report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 76 transactions on file: 0 with code P, 10 with code S and 40 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Carvajal Alejandra | Chief Legal Officer | A Award | 450,000 | Not measured | Not measured |
| Aug 3, 2026 | Carvajal Alejandra | Chief Legal Officer | A Award | 100,000 | Not measured | Not measured |
| Jul 24, 2026 | Fuchs Charles S. | Director | A Award | 118,000 | Not measured | Not measured |
| Jun 17, 2026 | Gilbert Halley E | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Ashworth Alan | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Jones Elaine V | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Meyers James R | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Young Matthew P. | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Mohindru Mani | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 17, 2026 | Su Zhen | Director | A Award | 59,000 | Not measured | Not measured |
| Jun 15, 2026 | Ogden Christopher | Chief Financial Officer | S Sale | 1,624 | $3.05 | $4,953 |
| Mar 17, 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | S Sale | 31,492 | $6.42 | $202,273 |
| Mar 17, 2026 | Ogden Christopher | Chief Financial Officer | S Sale | 19,323 | $6.42 | $124,112 |
| Mar 17, 2026 | Chu Yu-Waye | Chief Medical Officer | S Sale | 21,279 | $6.42 | $136,675 |
| Mar 17, 2026 | McCarthy Sean A. | CEO | S Sale | 118,969 | $6.42 | $764,138 |
| Feb 2, 2026 | McCarthy Sean A. | CEO | A Award | 980,000 | Not measured | Not measured |
| Feb 2, 2026 | Ogden Christopher | Chief Financial Officer | A Award | 325,000 | Not measured | Not measured |
| Feb 2, 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | A Award | 250,000 | Not measured | Not measured |
| Feb 2, 2026 | Chu Yu-Waye | Chief Medical Officer | A Award | 300,000 | Not measured | Not measured |
| Feb 2, 2026 | Ogden Christopher | Chief Financial Officer | A Award | 90,000 | Not measured | Not measured |
| Feb 2, 2026 | McCarthy Sean A. | CEO | A Award | 210,000 | Not measured | Not measured |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | A Award | 50,000 | Not measured | Not measured |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | A Award | 50,000 | Not measured | Not measured |
| Feb 2, 2026 | Lester Rachael | Chief Business Officer | A Award | 20,000 | Not measured | Not measured |
| Feb 2, 2026 | Chu Yu-Waye | Chief Medical Officer | A Award | 75,000 | Not measured | Not measured |
| Feb 2, 2026 | BELVIN MARCIA | SVP, Chief Scientific Officer | A Award | 60,000 | Not measured | Not measured |
| Nov 6, 2025 | McCarthy Sean A. | CEO | M Exercise | 101,793 | $1.59 | $161,851 |
| Nov 6, 2025 | McCarthy Sean A. | CEO | S Sale | 101,793 | $4.54 | $461,906 |
| Nov 6, 2025 | McCarthy Sean A. | CEO | M Exercise | 101,793 | Not measured | Not measured |
| Oct 20, 2025 | Lester Rachael | Chief Business Officer | A Award | 650,000 | Not measured | Not measured |
| Sep 26, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | A Award | 36,300 | Not measured | Not measured |
| Sep 26, 2025 | McCarthy Sean A. | CEO | A Award | 285,000 | Not measured | Not measured |
| Sep 26, 2025 | McCarthy Sean A. | CEO | A Award | 570,000 | Not measured | Not measured |
| Sep 26, 2025 | Chu Yu-Waye | Chief Medical Officer | A Award | 43,750 | Not measured | Not measured |
| Sep 26, 2025 | Chu Yu-Waye | Chief Medical Officer | A Award | 87,500 | Not measured | Not measured |
| Sep 26, 2025 | Ogden Christopher | Chief Financial Officer | A Award | 78,250 | Not measured | Not measured |
| Sep 26, 2025 | Ogden Christopher | Chief Financial Officer | A Award | 39,150 | Not measured | Not measured |
| Sep 26, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | A Award | 18,150 | Not measured | Not measured |
| Jun 16, 2025 | Ogden Christopher | Chief Financial Officer | S Sale | 10,614 | $2.69 | $28,540 |
| Jun 16, 2025 | McCarthy Sean A. | CEO | S Sale | 55,511 | $2.69 | $149,264 |
| Jun 16, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | S Sale | 13,884 | $2.69 | $37,334 |
| Jun 13, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | M Exercise | 37,500 | Not measured | Not measured |
| Jun 13, 2025 | McCarthy Sean A. | CEO | M Exercise | 150,000 | Not measured | Not measured |
| Jun 13, 2025 | BELVIN MARCIA | SVP, Chief Scientific Officer | M Exercise | 37,500 | Not measured | Not measured |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | S Sale | 1,641 | $2.95 | $4,841 |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | M Exercise | 37,500 | Not measured | Not measured |
| Jun 13, 2025 | McCarthy Sean A. | CEO | M Exercise | 150,000 | Not measured | Not measured |
| Jun 13, 2025 | Ogden Christopher | Chief Financial Officer | M Exercise | 37,500 | Not measured | Not measured |
| Jun 11, 2025 | Jones Elaine V | Director | A Award | 38,000 | Not measured | Not measured |
| Jun 11, 2025 | Gilbert Halley E | Director | A Award | 38,000 | Not measured | Not measured |
The full Form 4 history is on the CTMX company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.